Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To evaluate the long-term outcomes of ultrasound-guided thermal ablation for Bethesda III/IV thyroid nodules
To evaluate and predict the long-term clinical outcomes of ultrasound-guided thermal ablation for Bethesda III/IV thyroid nodules
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| ultrasound-guided thermal ablation | ultrasound-guided thermal ablation |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| ultrasound-guided thermal ablation | Procedure | microwave ablation, radio frequency ablation, laser ablation |
|
| Measure | Description | Time Frame |
|---|---|---|
| volume reduction rate | The volume reduction rate (VRR)was calculated by the equations: VRR=([initial volume-final volume] × 100)/initial volume | through study completion, an average of 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| rate of complications | complications of ablation | 1 week |
| rate of nodule regrowth | Regrowth was defined as ≥50% volume increase compared to the previously recorded smallest volume during the follow-up |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
patients with Bethesda III/IV thyroid nodules
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Lin Yan | Contact | 13811237313 | 86 | gemma-y@163.com |
| Name | Affiliation | Role |
|---|---|---|
| Yukun Luo | Chinese PLA General Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Chinese PLA General Hospital | Recruiting | Beijing | Beijing Municipality | 100853 | China |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D016606 | Thyroid Nodule |
| ID | Term |
|---|---|
| D013964 | Thyroid Neoplasms |
| D004701 | Endocrine Gland Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
Not provided
Not provided
| ID | Term |
|---|---|
| D020728 | Transurethral Resection of Prostate |
| ID | Term |
|---|---|
| D011468 | Prostatectomy |
| D013521 | Urologic Surgical Procedures, Male |
| D013520 | Urologic Surgical Procedures |
| D013519 | Urogenital Surgical Procedures |
Not provided
Not provided
Not provided
Not provided
Not provided
| through study completion, an average of 6 months |
| rate of change of thyroid function | thyroid function test, including free triiodothyronine, free thyroxine, thyroid stimulating hormone, thyroid peroxidase antibody and anti-thyroglobulin antibodies | through study completion, an average of 6 months |
| rate of delayed surgery | patients underwent surgery after ablation because of anxiety or unsatisfactory about the volume reduction | through study completion, an average of 1 year |
| cosmetic score | The cosmetic score was assessed by a physician (1, no palpable mass; 2, no cosmetic problem but palpable mass; 3, a cosmetic problem on swallowing only; and 4, a readily detected cosmetic problem) | through study completion, an average of 6 months |
| symptom score | The symptom score was self-measured by patients using a 10-cm visual analogue scale (grade 0-10) | through study completion, an average of 6 months |
| rate of disappearance | complete disappearance of ablated nodule on ultrasound and contrast-enhanced ultrasound | through study completion, an average of 6 months |
| Chinese PLA General Hospital | Not yet recruiting | Beijing | China |
| D006258 |
| Head and Neck Neoplasms |
| D004700 | Endocrine System Diseases |
| D013959 | Thyroid Diseases |
| D013514 | Surgical Procedures, Operative |